Eli Lilly and Company

Associate - M&Q Center of Excellence (CoE), New Site Learning & Development

United States

Not SpecifiedCompensation
Entry Level & New Grad, Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Job Description

Position Overview

The Global Manufacturing and Quality Learning and Development (GMQLD) team is dedicated to delivering learning solutions that empower Lilly’s Manufacturing and Quality organizations to achieve our mission: making medicine with safety first and quality always. This role is responsible for supporting the execution of the L&D program build and L&D Site Team onboarding to enable operational readiness and production of medicines at new Lilly manufacturing sites globally. The role requires an understanding of L&D processes and systems enabling detailed activities and organization to enable site-specific needs aligned with global practices while ensuring a high level of audit and inspection readiness.

Employment Type

Full-time

Location Type

Not Specified

Salary

Not Specified

Key Responsibilities

New Manufacturing Site Learning and Development Support:

  • Support the learning and development needs of new sites starting at site announcement through site operational readiness.
  • Manage project plans and Smartsheet driving activities for L&D site program build.
  • Own and conduct curricula architecture, course and curricula management activities.
  • Responsible for data analysis to inform New Site curricula and other activities.
  • Serve as subject matter expert on global L&D processes.
  • Serve as technical resource on global L&D technologies.
  • Provide ongoing coaching and guidance to site L&D resources.
  • Enable communication mechanisms across new sites to drive shared learnings.
  • Provide reports as required to inform updates or drive actions.
  • Support onboarding and qualification of New Site L&D Team.

Business Partner Relationships:

  • Serve as liaison with third-party resources managing learning plan administration.
  • Understand CoE processes, tools, etc. to ensure alignment of global activities with local site needs.
  • Partner with cross-functional teams and the Global MQ L&D CoE and L&D Networks to align on learning priorities.
  • Actively participate in Network L&D meetings to remain connected to the L&D community.
  • Support change management and communication for new or updated training programs.
  • Anticipate and resolve project/program issues, escalating as appropriate.

Basic Requirements:

  • Bachelor’s degree.
  • 2 years of training and facilitation experience in a manufacturing environment.
  • Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization and/or visas for this role.

Additional Skills/Preferences:

  • MS Office experience.
  • Learning Management System experience.
  • Experience in regulated industries.
  • Knowledge of adult learning principles and instructional design.
  • Strong communication and organizational skills.
  • Problem-solving mindset with attention to detail and quality.
  • Ability to work cross-functionally and influence without authority.
  • Project management experience.
  • Training and facilitation experience.
  • Experience planning and delivering events/programs.
  • Strong communication skills; written, verbal, and active listening.
  • Strong collaboration with colleagues.

Company Information

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing, and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Skills

Learning and Development (L&D)
Project Management
Smartsheet
Onboarding
Audit Readiness
Inspection Readiness
Global Practices
Operational Readiness

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI